Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24 (5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Zorac
Active Ingredient: Tazarotene 0.5mg/g
Dosage Form: Topical gel
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan Inc., Waco, Texas, United States of America
Product: Zorac
Active Ingredient: Tazarotene 1mg/g
Dosage Form: Topical gel
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturer: Allergan Inc., Waco, Texas, United States of America
Dated this 9th day of September 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).